SEDIA BIOSCIENCES CORPORATION

ADVANCING ACCESS TO CARE THROUGH INNOVATION

Sedia Bioscience’s mission is to advance global access to healthcare by developing innovative disease surveillance and monitoring tools, expanding accessible point-of-care diagnostic testing into both technology-rich and resource-limited settings and providing cost-effective specimen collection devices.

ABOUT SEDIA

Learn More About Us

Sedia Biosciences is a privately held Delaware-registered medical device and diagnostics company founded in 2009 and based in Beaverton, Oregon, USA. Our commitment is to become a leader in three areas intended to advance global access to care:

state-of-the-art rapid point of care diagnostic assays
novel epidemiological disease surveillance assays and other public health tools and
innovative clinical specimen collection devices to improve and facilitate remote collection of specimens for follow-up testing.

HIV RECENCY ASSAYS

Enzyme immunoassays designed to distinguish recent HIV infections from long-term ones as a means to measure incidence of new HIV infections. We are also developing assays that will target recent infections which have the highest risk of transmission to enable aggressive treatment, follow-up, and customized therapy.

RAPID POINT-OF-CARE ASSAYS

Rapid cost-effective assays that provide results from a variety of specimens, including whole and finger-stick blood, serum, plasma, oral fluid, and other clinical specimens. Most of our assays are focused on infectious diseases. However, we are developing rapid assays that identify other disease markers as well.

SPECIMEN COLLECTION DEVICES

Devices intended to collect, stabilize, and transport specimens from the point-of-care to the clinical laboratory. Designed to be cost-effective, robust, and provide a high yield of usable analytes, such as DNA, proteins, antibodies, enzymes and other biomarkers.

GENOMICS SERVICES

Solutions for genomic analysis in human, plant, and animal systems. We focus on applications combining next-generation DNA sequencing in combination with fractional sequencing technologies.

ORDER OUR PRODUCTS

Like what you see or interested in one of our products?
Request a quote today!

Request for Price Quotation

OUR PRODUCTS & SERVICES

Innovative Technology To Fight Global Pandemics

Sedia is a leading developer of the newest generation of in vitro diagnostic tests. We are dedicated to advancing access to medical care by developing innovative diagnostic and monitoring products that enable more cost effective and expanded testing for infectious diseases and other conditions.

CONTACT US

Want to know more or have any questions? Send us a message!